Dabigatran Versus Warfarin in Patients With Atrial Fibrillation

Nagarakanti, Rangadham; D. Ezekowitz, Michael; Oldgren, Jonas; Yang, Sean; R. Chernick, Michael; H. Aikens, Timothy; Flaker, Greg; Brugada, Josép; Kamenský, Gabriel; Parekh, Amit; Reilly, Paul; Yusuf, Salim; J. Connolly, Stuart

doi:10.1161/circulationaha.110.977546

Public

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation

Published in Circulation • Jan 4, 2011

Authors:

Rangadham Nagarakanti

Michael D. Ezekowitz

Jonas Oldgren

Abstract

BACKGROUND: The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial compared dabigatran 110 mg BID (D110) and 150 mg BID (D150) with warfarin for stroke prevention in 18 113 patients with nonvalvular atrial fibrillation. METHODS AND RESULTS: Cardioversion on randomized treatment...

Subject

Medicine

Warfarin

Dabigatran

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!